chloroquine has been researched along with Anti-Phospholipid Antibody Syndrome in 7 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Antiphospholipid syndrome is an autoimmune disease that is characterised by tendency to thrombosis, obstetrical and hematological complications." | 1.33 | Nocardiosis in a patient with primary anti-phospholipid syndrome. ( Altinay, G; Ermantaş, N; Okten, O; Oktun, MT; Soy, M; Tunçbilek, N; Turgut, B, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dos Reis Neto, ET | 1 |
| Kakehasi, AM | 1 |
| de Medeiros Pinheiro, M | 1 |
| Ferreira, GA | 1 |
| Marques, CDL | 1 |
| da Mota, LMH | 1 |
| Dos Santos Paiva, E | 1 |
| Pileggi, GCS | 1 |
| Sato, EI | 1 |
| Reis, APMG | 1 |
| Xavier, RM | 1 |
| Provenza, JR | 1 |
| Caldas, CA | 1 |
| de Carvalho, JF | 1 |
| Katz, SJ | 1 |
| Russell, AS | 1 |
| Soy, M | 1 |
| Oktun, MT | 1 |
| Tunçbilek, N | 1 |
| Ermantaş, N | 1 |
| Okten, O | 1 |
| Altinay, G | 1 |
| Turgut, B | 1 |
| Evereklioglu, C | 1 |
| Suarez, IM | 1 |
| Diaz, RA | 1 |
| Aguayo Canela, D | 1 |
| Pujol de la Llave, E | 1 |
| Wallace, DJ | 1 |
3 reviews available for chloroquine and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases.
Topics: Antimalarials; Antiphospholipid Syndrome; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; | 2020 |
Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action.
Topics: Annexin A5; Antimalarials; Antiphospholipid Syndrome; Antirheumatic Agents; Cardiovascular Diseases; | 2011 |
The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review.
Topics: Antimalarials; Antiphospholipid Syndrome; Autoimmune Diseases; Chloroquine; Controlled Clinical Tria | 1996 |
4 other studies available for chloroquine and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Primary antiphospholipid syndrome with and without Sneddon's syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Chloroquine; Female; Glucocorticoids; Hum | 2011 |
Nocardiosis in a patient with primary anti-phospholipid syndrome.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Antirheumatic Age | 2006 |
The treatment schedule and historical naming process of Behçet disease.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Antirheumatic Agents; Behcet Syndrome | 2007 |
Correction of severe thrombocytopenia with chloroquine in the primary antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Antirheumatic Agents; Chloroquine; Female; Follow-Up Studies; Huma | 1996 |